Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.03
0.01 (0.98%)
At close: Aug 15, 2025, 3:59 PM
1.03
0.00%
After-hours: Aug 15, 2025, 07:10 PM EDT

Clearmind Medicine Balance Sheet Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Cash & Equivalents
6.57M 5.43M 175.77K 4.6M
Short-Term Investments
289.39K 62.27K 264.45K n/a
Long-Term Investments
n/a 23.85K 20K 20K
Other Long-Term Assets
7.19K 14.31K 290.49K 20K
Receivables
180.88K 240.32K 37.42K 129.8K
Inventory
n/a -40.74K n/a n/a
Other Current Assets
n/a 40.74K 95.97K 160.87K
Total Current Assets
7.09M 5.79M 593.31K 4.92M
Property-Plant & Equipment
51.66K 1.25K 66.38K 20.58K
Goodwill & Intangibles
108.33K 119.31K 177.8K 198.04K
Total Long-Term Assets
167.18K 158.71K 534.66K 238.62K
Total Assets
7.26M 5.95M 1.13M 5.16M
Account Payables
526.06K 617K 1.03M 281.53K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
3.52M 4.31M 1.43M -68.96K
Total Current Liabilities
4.13M 4.97M 2.64M 357.15K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
16.42K n/a 1.96M n/a
Total Liabilities
4.15M 4.97M 2.64M 357.15K
Total Debt
53.14K n/a 52.4K n/a
Common Stock
24.17M 17.13M 9.15M 7.91M
Retained Earnings
-24.02M -18.77M -13.85M -4.44M
Comprehensive Income
-21.25K -15.37K 643.94K 1.34M
Shareholders Equity
3.11M 1.36M -1.51M 4.8M
Total Investments
289.39K 86.11K 264.45K 20K